Home Merck buys Swiss biotech with promising cancer drug
 

Keywords :   


Merck buys Swiss biotech with promising cancer drug

2014-12-18 19:05:10| Biotech - Topix.net

Drugmaker Merck says it's bought a Swiss biotech company developing cancer drugs as part of its strategy to be a top player in cancer, one of the hottest pharmaceutical research areas. Merck & Co., based in Kenilworth, New Jersey, will pay up to $110 million upfront to OncoEthix.

Tags: drug cancer swiss promising

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.06Tropical Depression Two Graphics
28.06Tropical Depression Two Public Advisory Number 1
28.06Summary for Tropical Depression Two (AT2/AL022024)
28.06Tropical Depression Two Forecast Advisory Number 1
28.06Tropical Depression Two Forecast Discussion Number 1
28.06Tropical Depression Two Wind Speed Probabilities Number 1
28.06Cattle producers celebrate Supreme Court decision to rein in administrative overreach
28.06Diversified Labeling Solutions expands RFID capabilities
More »